403511-47-7

Upstream product

• 403511-40-0 C₁₃H₁₇BrO₂ 
• 403511-45-5 2-[4-(tert-butyl-dimethyl-silanyloxy)-1-ethyl-cyclohex-2-enyl]-N,N-dimethyl-acetamide 
• 403511-42-2 C₁₇H₂₆BrNO₂ 
• 403511-41-1 C₁₇H₂₄BrNO₂ 
• 403511-44-4 2-[(1R,4S,4aR,5S,8R,8aS)-8-(tert-Butyl-dimethyl-silanyloxy)-5-ethyl-1,4,4a,5,6,7,8,8a-octahydro-1,4-methano-naphthalen-5-yl]-N,N-dimethyl-acetamide 
• 403511-43-3 2-((1R,4S,4aR,5S,8R,8aS)-5-Ethyl-8-hydroxy-1,4,4a,5,6,7,8,8a-octahydro-1,4-methano-naphthalen-5-yl)-N,N-dimethyl-acetamide 
• 403511-46-6 2-[(1S,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-1-ethyl-cyclohex-2-enyl]-ethanol 

Relevant academic research and scientific papers

Diastereocontrolled synthesis of an enantiopure 4,4-disubstituted cyclohex-2-en-ol: A new route to (+)-quebrachamine

A diastereoselective route to an enantiopure 4,4-disubstituted cyclohex-2-en-1-ol has been developed using the synthetic equivalent of chiral 4-hydroxycyclohex-2-en-1-one. Its stereochemistry has been determined by its transformation into the Aspidosperma